Clinical Trial Update: Reduced-dose Botox for Urgency Incontinence Among Elder Females [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating reduced-dose onabotulinumtoxinA (Botox) for urgency incontinence in elderly women with overactive bladder. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Overactive Bladder, Urinary Incontinence in Old Age | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING